Trial Details
UNKNOWNBasic Information
| Clinical ID | c2641 |
|---|---|
| Identifier | NCT03172377 |
| Trial Title | Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease in Remission|Crohn Disease |
| Interventions | OTHER: Lengthening adalimumab dosing interval |
Participant Information
| Sponsor | Radboud University Medical Center |
|---|---|
| City | Gelderland |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2017-05-03 |
|---|---|
| Primary Completion Date | 2022-10 |
| Completion Date | 2022-10 |